Our mission at Semorex is to develop and commercialize innovative technologies based on our proprietary imprinted polymers for
- Detection of toxic proteins (i.e., Ricin).
- Development of novel therapeutics for treatment of major diseases by selective removal of proteins from the GI tract (i.e., Gliadin - for Celiac disease, TNFa - for inflammatory bowel diseases, Ghrelin - for obesity treatment).
We have also developed
- Novel, non-toxic small-molecule therapeutics for cancer.
- Novel diagnosis for systemic fungal infection (lateral flow device, mass spectroscopy).